Synthetic Surfactants

David Sweet was the local PI on the CHF5633 first in human trial as well as the follow up study which was sponsored by Chiesi ® pharmaceuticals and has received speakers fees from them in the past. No other financial interests to declare. Jan Johansson has no current COI to declare. Fernando Moya received an honorarium from Chiesi for participation on an "RDS Expert Panel".
Source: Seminars in Fetal and Neonatal Medicine - Category: Perinatology & Neonatology Authors: Source Type: research